MOS MOSAIC CO
Agricultural Chemicals · NYSE · SEC CIK 1285785 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.0%
TTM net income YoY-191.3%
TTM EPS YoY-191.5%
Revenue 3-yr CAGR-7.5%
Net income 3-yr CAGR—
Margins
Gross margin7.4%
Operating margin-5.1%
Net margin-9.4%
FCF margin-6.8%
EBITDA margin4.7%
Returns
ROE-9.3%
ROA-4.6%
ROIC (approx.)-2.9%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets52.5%
Debt / equity0.48x
Current ratio1.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.45x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue11.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $12.05B | $11.12B |
| Cost of revenue | $10.15B | $9.61B |
| Gross profit | $1.90B | $1.51B |
| SG&A expense | $533.90M | $496.90M |
| Operating income | $821.50M | $621.50M |
| Interest expense | $241.50M | $230.00M |
| Pretax income | $1.21B | $315.40M |
| Income tax | $639.80M | $186.70M |
| Net income | $540.70M | $174.90M |
| EBITDA | $1.87B | $1.65B |
| EPS (basic) | 1.70 | 0.55 |
| EPS (diluted) | 1.70 | 0.55 |
| Dividends declared per share | 0.88 | 0.85 |
| Weighted avg. shares (diluted) | 318.90M | 320.70M |
| Banking | ||
| Net interest income | -$187.70M | -$182.80M |
| Balance sheet | ||
| Cash & equivalents | $276.60M | $305.00M |
| Receivables | $1.08B | $1.11B |
| Inventory | $3.36B | $2.55B |
| Current assets | $5.24B | $4.50B |
| PP&E, net | $13.98B | $13.35B |
| Goodwill | $1.01B | $1.06B |
| Total assets | $24.48B | $22.92B |
| Current liabilities | $3.98B | $4.17B |
| Short-term debt | $43.10M | $847.10M |
| Long-term debt | $4.25B | $3.33B |
| Total debt | $4.29B | $4.18B |
| Total liabilities | $12.25B | $11.31B |
| Shareholders' equity | $12.08B | $11.48B |
| Net debt | $4.02B | $3.87B |
| Shares outstanding | 317.41M | 316.93M |
| Cash flow statement | ||
| Operating cash flow | $824.80M | $1.30B |
| Capital expenditure | $1.36B | $1.25B |
| Free cash flow | -$534.60M | $47.40M |
| Investing cash flow | -$1.31B | -$1.26B |
| Financing cash flow | $452.00M | -$131.90M |
| Depreciation & amortization | $1.05B | $1.03B |
| Stock-based compensation | $30.70M | $31.80M |
| Dividends paid | $280.40M | $270.70M |
| Share buybacks | $0 | $235.40M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.